Comments
Commented by Nico Popp on February 8th, 2021 | 07:30 CET
Fresenius, Fresenius Medical Care, Q&M Dental: Healthy returns await here
Healthcare stocks have been in demand not just since the pandemic, but the pandemic is a sure game-changer for the industry in the long term. Demand for consumables and tests will continue to rise because this much seems certain: the Coronavirus will remain with us and possibly return year after year like a wave of influenza. Companies in the industry can profit from this. We present three stocks.
Read
Commented by Stefan Feulner on February 8th, 2021 | 07:20 CET
Xiaomi, Marble Financial, Deutsche Telekom - you should check this!
Corona has been dominating life in Germany for a year now. Whether professionally or privately - the pandemic has already left deep scars. The number of insolvencies fell last year thanks to government Corona aid and the suspension of the obligation to file for bankruptcy despite the economic crisis. Due to the extreme backlog of insolvencies and the increase in indebted households due to the loss of thousands of jobs, it is probably unavoidable that there will be a wave of bankruptcies. Controlling one's finances will become all the more crucial.
Read
Commented by Stefan Feulner on February 8th, 2021 | 07:10 CET
TUI, Pollux Properties, Formycon - When will the starting signal be given?
Currently, no question is heard more often: When will we see a return to normality? Light at the end of the tunnel is promised by the vaccines that are gradually being approved. The drugs against the Coronavirus, which are currently in various research phases, promise potential and could allow people to go about their daily lives as usual in the future. Through the action of these drugs, free, carefree travel could once again be possible. A boom seems pre-programmed.
Read
Commented by Nico Popp on February 8th, 2021 | 07:00 CET
Alibaba, GS Holdings, Lufthansa: Asia as an investment target
When it comes to promising growth regions, investors have little choice: Asia has been the growth region par excellence for many years. Although Africa and South America have also been repeatedly proclaimed as promising, Asia now has a unique dynamism. In addition to production, Asia has long been an economic region driven by consumption. Every year, millions of Asians earn a modest amount of wealth - and want to treat themselves. We present three interesting investment ideas.
Read
Commented by Stefan Feulner on February 5th, 2021 | 12:22 CET
Deutsche Bank, wallstreet:online, Bayer - The return of the giants!
The dinosaurs of the German economy report good news. Deutsche Bank has made it into the black for six years, and Bayer AG is making progress in settling the Monsanto debacle. Among online brokers, the wheat was separated from the chaff last week and we present you with an online broker you can trust!
Read
Commented by Nico Popp on February 5th, 2021 | 10:35 CET
NIO, Varta, Nevada Copper: Here's where the e-car boom is still favorable
Electric cars are very much in vogue. While Tesla and Co. were still rare a few years ago, the US pioneer models can now be found more and more often on German roads. Plug-in hybrids are also in great demand, especially among premium brands - buyers benefit from subsidies and have a clear conscience at the same time. It remains to be seen whether it makes sense to chauffeur heavy batteries around in cars that already weigh several tons. The fact is, however, that the trend is intact and will continue: E-cars are booming. While some manufacturers are already expensive, there are still opportunities along the value chain. We present three titles.
Read
Commented by André Will-Laudien on February 5th, 2021 | 09:42 CET
Triumph Gold, Kinross Gold, Aston Martin Lagonda - Goldfinger in trouble!
The recent surge in the major stock markets was coupled with the hope that inflation would get some traction globally. Given the rampant government spending on pandemic response and rising stimulus budgets for the economy, inflation could have been expected. Due to base effects at the beginning of the year, multiple eco-taxes increased +1.4% in the eurozone. However, as markets tend to look at consumption, administered price increases tend to be counterproductive as they further weaken purchasing power. No good news for the precious metals, they had to give up the previous week's gains again completely: Gold from USD 1,875 to USD 1,790 and silver down by a whole 10% to USD 26.2, which somehow does not fit at all to the USD 1,000 price target of the Robinhood traders.
Read
Commented by Stefan Feulner on February 4th, 2021 | 09:41 CET
BYD, Revez, Alibaba - Profiting from the digital transformation!
Everything is going digital, and the Corona pandemic is accelerating the process. Shopping online at Amazon or Zalando was already relatively normal before the outbreak of the virus. Now, however, new things like homeschooling, home offices and Zoom conferences are being added. The world is becoming more and more digital. Companies' business models are also changing. Be part of it and participate in the digital transformation.
Read
Commented by André Will-Laudien on February 4th, 2021 | 09:10 CET
Kleos Space, OHB, Airbus, Boeing - SpaceX, into orbit with Elon Musk!
Elon Musk might be the most dazzling Wall Street figure of the last 2 years next to Jeff Bezos. His talents are visions with which he regularly reinvents himself. Whether it is a battery that is supposed to last millions of kilometers or simply the possibility for wealthy individuals to travel into orbit with SpaceX - all this and also the most famous electric vehicle in the world, "Tesla" originate from his imagination. The development of the share price of Tesla itself is fantastic. It achieved a return of 450% in 12 months, calculated from the low in March 2020, the value has increased tenfold. The latest rumor comes from the Chinese press and talks about upcoming cooperation with the Chinese car manufacturer BYD, in which Warren Buffet also holds shares. Here is where the circle closes again.
Read
Commented by Nico Popp on February 4th, 2021 | 08:15 CET
BioNTech, Cardiol Therapeutics, Johnson & Johnson: biotech gems from the well-known to the unknown
If there's one industry that's rightfully making big profits these days, it's healthcare companies. The pandemic has kissed the industry awake. In addition to the current relevance around Covid treatment, test procedures, or even vaccinations, there is also a growing awareness that medical innovation depends on research. More and more investors are willing to push promising projects and the general conditions for this could not be better. There is a consensus in politics, society and business that health is the highest good.
Read